Guest blog: Gwilym Roberts on the IPO’s mission to China

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Guest blog: Gwilym Roberts on the IPO’s mission to China

Last week saw a delegation from UK IPO and the Foreign and Commonwealth Office visit China. CIPA Council member Gwilym Roberts reports on the trip

The $21 billion flotation of Chinese e-commerce giant Alibaba has again focused the minds of commentators on the continuing difficulties the IP system faces in China. However, there is plenty of good news and the recent IPO/FCO delegation to China achieved both short-term and long-term goals not least in relation to Alibaba itself.

Baroness Neville-Rolfe

The delegation was headed by the new IP minister, Baroness Neville-Rolfe (pictured, right), with judicial weight added by Mr Justice Colin Birss and further expertise contributed by the IPO, CIPA (myself), ITMA (represented by Catherine Wolfe of Boult Wade Tennant; Rachel Wilkinson-Duffy of Baker & Mackenzie; and Rob Furneaux of Sipara) and industry representatives. The goals of the mission were many: to ensure that the UK’s IP needs in China were well understood; to build stronger relations between the countries at multiple levels; and to extoll the virtues of the UK and European IP systems. The trip was also ambitious in its scope. The delegation took in eight cities in five days and spoke to officials from central government as well as the staff of regional patent offices, universities and local businesses. That allowed the delegation’s message to be spread at every level and a whole range of new links to be built.

CIPA was delighted to be represented throughout, with an opportunity to speak at the Beijing IP symposium on day one and to meet officials and business partners in Suzhou, Nanjing and Hong Kong. We have returned with stronger links to both national and local patent offices and enforcement units as well as patent attorney associations and academic institutions, all of which will help to strengthen the UK’s reputation as a global patent quality hub. The IPO’s international reputation will only have been strengthened by the opportunity to exchange best practices. Andy Bartlett (a patent specialist), Nathan Abraham (trade marks) and Andrew Davidson (international development) all spoke authoritatively on various IP-related issues during the visit.

The visit was not all top-down stuff – there were significant specific achievements. Signing an agreement with Alibaba to assist in cracking down on counterfeiters was timely and one of the many highpoints of the trip. It also illustrates how seriously enhancing the IP regime is taken on both sides. CIPA was delighted to be part of the delegation and is proud of what it is already achieving.





more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article